Loading…
Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus
Vancomycin (VAN) minimum inhibitory concentrations (MICs) at the upper end of the susceptible range for Staphylococcus aureus ( S. aureus ), as measured by the Etest method, have been associated with poor clinical outcomes of S. aureus bloodstream infections, as has the isolate’s genetic background....
Saved in:
Published in: | European journal of clinical microbiology & infectious diseases 2019-05, Vol.38 (5), p.903-912 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3 |
container_end_page | 912 |
container_issue | 5 |
container_start_page | 903 |
container_title | European journal of clinical microbiology & infectious diseases |
container_volume | 38 |
creator | Falcón, Rocío Mateo, Eva Oltra, Rosa Giménez, Estela Albert, Eliseo Torres, Ignacio Navarro, David |
description | Vancomycin (VAN) minimum inhibitory concentrations (MICs) at the upper end of the susceptible range for
Staphylococcus aureus
(
S. aureus
), as measured by the Etest method, have been associated with poor clinical outcomes of
S. aureus
bloodstream infections, as has the isolate’s genetic background. Here, we assessed the impact of VAN MICs, as determined by a broth microdilution method (BMD) that incorporates incremental VAN concentrations between the conventional log
2
dilutions, isolate susceptibility to killing by human phagocytes, acting as a surrogate marker for bacterial cell wall thickness, and
S. aureus
genetic composition, on the development of complicated
S. aureus
bacteremia (SAB). We carried out a retrospective, observational single-center cohort study of 148 consecutive patients with SAB caused by methicillin-susceptible (MSSA) isolates (
n
= 113) or methicillin-resistant (MRSA) isolates (
n
= 35).
S. aureus
isolates were genotyped using a commercially available DNA microarray. Overall, VAN MICs of
S. aureus
isolates taken from complicated and uncomplicated SAB were comparable, irrespective of the testing method (
P
= 0.19 with BMD, and
P
= 0.94 with Etest). Likewise,
S. aureus
isolates in both comparison groups had the same susceptibility to killing by human phagocytes (
P =
0.5). Among the genes screened by the
S. aureus
DNA array, only
Sec
and
Sel
were differentially present among
S. aureus
isolates in both groups (overrepresented in those causing complications) and their presence was associated independently with complicated SAB in multivariate models adjusted for potentially relevant clinical covariates. Separate analysis of MSSA SAB episodes yielded similar results. |
doi_str_mv | 10.1007/s10096-019-03500-7 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2210232232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2210232232</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3</originalsourceid><addsrcrecordid>eNp9kUtLxDAUhYMozjj6B1xIwI2baF5tpksZfAwoLnxsQ5rejtW2qUm76L8344wKLoRwE7jfObnJQeiY0XNGqboIsWYpoSwjVCSUErWDpkyKhEihxC6a0kxIkikuJugghDcaRXOl9tFEUMUzkaVTVLyY1rpmtFWL75eLgE1bYF-Fd-xKHBtdXVnTQ4FzY3vw0FQG5yNe1aN1HXR9VQAJQ7DrY14DfuxN9zrWzjprh-g2eBjCIdorTR3gaLvP0PP11dPiltw93CwXl3fECpX0BLgsVUpZMqc2gdSyWCRIE1-U5Co1tkwZ5RSUNHOblyq3iVSilJxLWRiZixk62_h23n0MEHrdVHG0ujYtuCFozqNe8LgievoHfXODb-N0mjOVJooyziLFN5T1LgQPpe581Rg_akb1OgO9yUDHDPRXBlpF0cnWesgbKH4k358eAbEBQmy1K_C_d_9j-wnXQpIH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2176570121</pqid></control><display><type>article</type><title>Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus</title><source>Springer Nature</source><creator>Falcón, Rocío ; Mateo, Eva ; Oltra, Rosa ; Giménez, Estela ; Albert, Eliseo ; Torres, Ignacio ; Navarro, David</creator><creatorcontrib>Falcón, Rocío ; Mateo, Eva ; Oltra, Rosa ; Giménez, Estela ; Albert, Eliseo ; Torres, Ignacio ; Navarro, David</creatorcontrib><description>Vancomycin (VAN) minimum inhibitory concentrations (MICs) at the upper end of the susceptible range for
Staphylococcus aureus
(
S. aureus
), as measured by the Etest method, have been associated with poor clinical outcomes of
S. aureus
bloodstream infections, as has the isolate’s genetic background. Here, we assessed the impact of VAN MICs, as determined by a broth microdilution method (BMD) that incorporates incremental VAN concentrations between the conventional log
2
dilutions, isolate susceptibility to killing by human phagocytes, acting as a surrogate marker for bacterial cell wall thickness, and
S. aureus
genetic composition, on the development of complicated
S. aureus
bacteremia (SAB). We carried out a retrospective, observational single-center cohort study of 148 consecutive patients with SAB caused by methicillin-susceptible (MSSA) isolates (
n
= 113) or methicillin-resistant (MRSA) isolates (
n
= 35).
S. aureus
isolates were genotyped using a commercially available DNA microarray. Overall, VAN MICs of
S. aureus
isolates taken from complicated and uncomplicated SAB were comparable, irrespective of the testing method (
P
= 0.19 with BMD, and
P
= 0.94 with Etest). Likewise,
S. aureus
isolates in both comparison groups had the same susceptibility to killing by human phagocytes (
P =
0.5). Among the genes screened by the
S. aureus
DNA array, only
Sec
and
Sel
were differentially present among
S. aureus
isolates in both groups (overrepresented in those causing complications) and their presence was associated independently with complicated SAB in multivariate models adjusted for potentially relevant clinical covariates. Separate analysis of MSSA SAB episodes yielded similar results.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-019-03500-7</identifier><identifier>PMID: 30729396</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Antibiotics ; Bacteremia ; Biomedical and Life Sciences ; Biomedicine ; Cell walls ; Deoxyribonucleic acid ; DNA ; DNA chips ; DNA microarrays ; Drug resistance ; Internal Medicine ; Medical Microbiology ; Methicillin ; Original Article ; Pathogens ; Penicillin ; Phagocytes ; Staphylococcus aureus ; Test procedures ; Vancomycin ; Wall thickness</subject><ispartof>European journal of clinical microbiology & infectious diseases, 2019-05, Vol.38 (5), p.903-912</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>European Journal of Clinical Microbiology & Infectious Diseases is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3</citedby><cites>FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3</cites><orcidid>0000-0003-3010-4110</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30729396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Falcón, Rocío</creatorcontrib><creatorcontrib>Mateo, Eva</creatorcontrib><creatorcontrib>Oltra, Rosa</creatorcontrib><creatorcontrib>Giménez, Estela</creatorcontrib><creatorcontrib>Albert, Eliseo</creatorcontrib><creatorcontrib>Torres, Ignacio</creatorcontrib><creatorcontrib>Navarro, David</creatorcontrib><title>Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus</title><title>European journal of clinical microbiology & infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>Vancomycin (VAN) minimum inhibitory concentrations (MICs) at the upper end of the susceptible range for
Staphylococcus aureus
(
S. aureus
), as measured by the Etest method, have been associated with poor clinical outcomes of
S. aureus
bloodstream infections, as has the isolate’s genetic background. Here, we assessed the impact of VAN MICs, as determined by a broth microdilution method (BMD) that incorporates incremental VAN concentrations between the conventional log
2
dilutions, isolate susceptibility to killing by human phagocytes, acting as a surrogate marker for bacterial cell wall thickness, and
S. aureus
genetic composition, on the development of complicated
S. aureus
bacteremia (SAB). We carried out a retrospective, observational single-center cohort study of 148 consecutive patients with SAB caused by methicillin-susceptible (MSSA) isolates (
n
= 113) or methicillin-resistant (MRSA) isolates (
n
= 35).
S. aureus
isolates were genotyped using a commercially available DNA microarray. Overall, VAN MICs of
S. aureus
isolates taken from complicated and uncomplicated SAB were comparable, irrespective of the testing method (
P
= 0.19 with BMD, and
P
= 0.94 with Etest). Likewise,
S. aureus
isolates in both comparison groups had the same susceptibility to killing by human phagocytes (
P =
0.5). Among the genes screened by the
S. aureus
DNA array, only
Sec
and
Sel
were differentially present among
S. aureus
isolates in both groups (overrepresented in those causing complications) and their presence was associated independently with complicated SAB in multivariate models adjusted for potentially relevant clinical covariates. Separate analysis of MSSA SAB episodes yielded similar results.</description><subject>Antibiotics</subject><subject>Bacteremia</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell walls</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA chips</subject><subject>DNA microarrays</subject><subject>Drug resistance</subject><subject>Internal Medicine</subject><subject>Medical Microbiology</subject><subject>Methicillin</subject><subject>Original Article</subject><subject>Pathogens</subject><subject>Penicillin</subject><subject>Phagocytes</subject><subject>Staphylococcus aureus</subject><subject>Test procedures</subject><subject>Vancomycin</subject><subject>Wall thickness</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kUtLxDAUhYMozjj6B1xIwI2baF5tpksZfAwoLnxsQ5rejtW2qUm76L8344wKLoRwE7jfObnJQeiY0XNGqboIsWYpoSwjVCSUErWDpkyKhEihxC6a0kxIkikuJugghDcaRXOl9tFEUMUzkaVTVLyY1rpmtFWL75eLgE1bYF-Fd-xKHBtdXVnTQ4FzY3vw0FQG5yNe1aN1HXR9VQAJQ7DrY14DfuxN9zrWzjprh-g2eBjCIdorTR3gaLvP0PP11dPiltw93CwXl3fECpX0BLgsVUpZMqc2gdSyWCRIE1-U5Co1tkwZ5RSUNHOblyq3iVSilJxLWRiZixk62_h23n0MEHrdVHG0ujYtuCFozqNe8LgievoHfXODb-N0mjOVJooyziLFN5T1LgQPpe581Rg_akb1OgO9yUDHDPRXBlpF0cnWesgbKH4k358eAbEBQmy1K_C_d_9j-wnXQpIH</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Falcón, Rocío</creator><creator>Mateo, Eva</creator><creator>Oltra, Rosa</creator><creator>Giménez, Estela</creator><creator>Albert, Eliseo</creator><creator>Torres, Ignacio</creator><creator>Navarro, David</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3010-4110</orcidid></search><sort><creationdate>20190501</creationdate><title>Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus</title><author>Falcón, Rocío ; Mateo, Eva ; Oltra, Rosa ; Giménez, Estela ; Albert, Eliseo ; Torres, Ignacio ; Navarro, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Antibiotics</topic><topic>Bacteremia</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell walls</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA chips</topic><topic>DNA microarrays</topic><topic>Drug resistance</topic><topic>Internal Medicine</topic><topic>Medical Microbiology</topic><topic>Methicillin</topic><topic>Original Article</topic><topic>Pathogens</topic><topic>Penicillin</topic><topic>Phagocytes</topic><topic>Staphylococcus aureus</topic><topic>Test procedures</topic><topic>Vancomycin</topic><topic>Wall thickness</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Falcón, Rocío</creatorcontrib><creatorcontrib>Mateo, Eva</creatorcontrib><creatorcontrib>Oltra, Rosa</creatorcontrib><creatorcontrib>Giménez, Estela</creatorcontrib><creatorcontrib>Albert, Eliseo</creatorcontrib><creatorcontrib>Torres, Ignacio</creatorcontrib><creatorcontrib>Navarro, David</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical microbiology & infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Falcón, Rocío</au><au>Mateo, Eva</au><au>Oltra, Rosa</au><au>Giménez, Estela</au><au>Albert, Eliseo</au><au>Torres, Ignacio</au><au>Navarro, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus</atitle><jtitle>European journal of clinical microbiology & infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>38</volume><issue>5</issue><spage>903</spage><epage>912</epage><pages>903-912</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>Vancomycin (VAN) minimum inhibitory concentrations (MICs) at the upper end of the susceptible range for
Staphylococcus aureus
(
S. aureus
), as measured by the Etest method, have been associated with poor clinical outcomes of
S. aureus
bloodstream infections, as has the isolate’s genetic background. Here, we assessed the impact of VAN MICs, as determined by a broth microdilution method (BMD) that incorporates incremental VAN concentrations between the conventional log
2
dilutions, isolate susceptibility to killing by human phagocytes, acting as a surrogate marker for bacterial cell wall thickness, and
S. aureus
genetic composition, on the development of complicated
S. aureus
bacteremia (SAB). We carried out a retrospective, observational single-center cohort study of 148 consecutive patients with SAB caused by methicillin-susceptible (MSSA) isolates (
n
= 113) or methicillin-resistant (MRSA) isolates (
n
= 35).
S. aureus
isolates were genotyped using a commercially available DNA microarray. Overall, VAN MICs of
S. aureus
isolates taken from complicated and uncomplicated SAB were comparable, irrespective of the testing method (
P
= 0.19 with BMD, and
P
= 0.94 with Etest). Likewise,
S. aureus
isolates in both comparison groups had the same susceptibility to killing by human phagocytes (
P =
0.5). Among the genes screened by the
S. aureus
DNA array, only
Sec
and
Sel
were differentially present among
S. aureus
isolates in both groups (overrepresented in those causing complications) and their presence was associated independently with complicated SAB in multivariate models adjusted for potentially relevant clinical covariates. Separate analysis of MSSA SAB episodes yielded similar results.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>30729396</pmid><doi>10.1007/s10096-019-03500-7</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-3010-4110</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0934-9723 |
ispartof | European journal of clinical microbiology & infectious diseases, 2019-05, Vol.38 (5), p.903-912 |
issn | 0934-9723 1435-4373 |
language | eng |
recordid | cdi_proquest_miscellaneous_2210232232 |
source | Springer Nature |
subjects | Antibiotics Bacteremia Biomedical and Life Sciences Biomedicine Cell walls Deoxyribonucleic acid DNA DNA chips DNA microarrays Drug resistance Internal Medicine Medical Microbiology Methicillin Original Article Pathogens Penicillin Phagocytes Staphylococcus aureus Test procedures Vancomycin Wall thickness |
title | Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A43%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vancomycin%20MICs%20and%20risk%20of%20complicated%20bacteremia%20by%20glycopeptide-susceptible%20Staphylococcus%20aureus&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Falc%C3%B3n,%20Roc%C3%ADo&rft.date=2019-05-01&rft.volume=38&rft.issue=5&rft.spage=903&rft.epage=912&rft.pages=903-912&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-019-03500-7&rft_dat=%3Cproquest_cross%3E2210232232%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2176570121&rft_id=info:pmid/30729396&rfr_iscdi=true |